The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries.

Article, Preprint English OPEN
Aguiar, Maíra; Stollenwerk, Nico; Halstead, Scott B.;
(2016)
  • Publisher: Public Library of Science (PLoS)
  • Journal: PLoS Neglected Tropical Diseases,volume 10,issue 12 (issn: 1935-2727, eissn: 1935-2735)
  • Publisher copyright policies & self-archiving
  • Related identifiers: doi: 10.1371/journal.pntd.0005179, doi: 10.1101/074062, pmc: PMC5176165
  • Subject: Research Article | Vaccines | Preventive Medicine | Infectious Diseases | Pathology and Laboratory Medicine | Infectious Disease Epidemiology | Vaccination and Immunization | Population groupings | Epidemiology | Neglected Tropical Diseases | People and places | Demography | Public and Occupational Health | Serology | Latin Americans | Immunology | Biology and Life Sciences | Tropical Diseases | Viral Diseases | bepress|Life Sciences|Biology | Ethnicities | RC955-962 | Dengue Fever | RA1-1270 | Public aspects of medicine | Death Rates | Medicine and Health Sciences | Arctic medicine. Tropical medicine | bepress|Medicine and Health Sciences|Public Health|Epidemiology

Background With approximately 3 billion people at risk of acquiring the infection, dengue fever is now considered the most important mosquito-borne viral disease in the world, with 390 million dengue infections occurring every year, of which 96 million manifest symptoms... View more
Share - Bookmark